◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › FLGT

Fulgent Genetics, Inc. (FLGT) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-07-09

Fulgent Genetics, Inc. (FLGT) operates in the Diagnostics & Research industry and is headquartered in El Monte, United States with about 1,315 employees. Its market capitalization is roughly $588 million. In the fiscal year ended 2025-12-31, FLGT reported $323M in revenue and ($60M) in net income.

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.

Interactive charts & full statements → Open the FLGT valuation workbench →

FLGT Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$323M$284M$289M$619M
Gross Profit$131M$107M$104M$367M
Operating Income (EBIT)($91M)($74M)($75M)$182M
Net Income($60M)($43M)($168M)$143M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

FLGT Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$71M$83M$84M$82M$74M
Gross Profit$22M$33M$36M$34M$28M
Operating Income (EBIT)($35M)($36M)($15M)($20M)($20M)
Net Income($25M)($23M)($7M)($19M)($12M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

FLGT Free Cash Flow History

FLGT Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$1.2B$1.2B$1.2B$1.4B
Total Liabilities$107M$91M$102M$116M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive FLGT viewer.

Other Companies in Diagnostics & Research

← FLGAll stocksFLL →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.